Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin-bound Paclitaxel Plus Nedaplatin in Advanced Cervical Cancer
NCT01667211Phase 2Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Nov 2011
- Primary completion
- Dec 2014
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Paclitaxel Micelles for Injection in Cervical Cancer (CC), sponsored by Chinese Academy of Medical Sciences. Primary endpoint: response rate at 1 year. Status: unknown.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT01667211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01667211.